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Abstract: Hepatitis E virus (HEV) is a human pathogen with increasing importance. The lack of
efficient cell culture systems hampers systematic studies on its replication cycle, virus neutralization
and inactivation. Here, several cell lines were inoculated with the HEV genotype 3c strain 47832c,
previously isolated from a chronically infected transplant patient. At 14 days after inoculation
the highest HEV genome copy numbers were found in A549 cells, followed by PLC/PRF/5
cells, whereas HepG2/C3A, Huh-7 Lunet BLR and MRC-5 cells only weakly supported virus
replication. Inoculation of A549-derived subclone cell lines resulted in most cases in reduced HEV
replication. However, the subclone A549/D3 was susceptible to lower virus concentrations and
resulted in higher virus yields as compared to parental A549 cells. Transcriptome analysis indicated
a downregulation of genes for carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 5
and 6, and an upregulation of the syndecan 2 (SDC2) gene in A549/D3 cells compared to A549 cells.
However, treatment of A549/D3 cells or A549 cells with CEACAM- or syndecan 2-specific antisera did
not influence HEV replication. The results show that cells supporting more efficient HEV replication
can be selected from the A549 cell line. The specific mechanisms responsible for the enhanced
replication remain unknown.
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1. Introduction
Hepatitis E virus (HEV) is the causative agent of acute hepatitis in humans. It causes worldwide
an estimated 20 million cases and 56,000 deaths every year [1]. Most of the cases occur in developing
countries where the virus is mainly transmitted by fecally contaminated drinking water. However,
hepatitis E cases are also increasingly recognized in industrial countries where HEV is mostly
zoonotically transmitted from pigs and wild boars [2]. In addition, chronic HEV infections of
immunosuppressed transplant patients, which may cause liver cirrhosis, have been increasingly
reported [3].
HEV particles are icosahedral and non-enveloped, although recent analyses of cell culture-derived
HEV suggest the presence of an additional enveloped particle fraction [4]. The HEV genome consists
of a single-stranded RNA with positive polarity. It contains the open reading frame (ORF) 1
encoding a non-structural polyprotein, ORF2 encoding the capsid protein and ORF3 encoding a small
phosphoprotein. Four main human-pathogenic genotypes of HEV have been defined. Genotypes 1
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and 2 exclusively infect humans, whereas genotypes 3 and 4 are zoonotic with main reservoirs in
domestic pigs and wild boars [2].
The knowledge on the HEV replication cycle is limited, mainly because of the inefficiency of
current cell culture models for HEV propagation. In addition, systematic studies on HEV neutralization
and inactivation are hampered by the lack of cell culture-based infectivity assays [5]. Although many
publications report the successful isolation of HEV using the human liver cell lines HepG2/C3A and
PLC/PRF/5 or the human lung carcinoma cell line A549, virus replication usually progresses very
slowly and infection with low amounts of virus results in failure of HEV replication [4–8]. The use of
novel cell lines has been recently described [9–11], but their broad applicability and robustness remains
to be proven. In addition, more efficiently replicating virus strains have been described [8,12,13].
One of them, designated as strain 47832c, has been recently isolated from a chronically infected
transplant patient in Germany [8].
The aim of this study was to improve the cell culture replication of a cell culture-adapted HEV
strain by testing different established cell lines as well as newly generated subclonal cell lines. Cell lines
that are more susceptible to HEV infection should be characterized in more detail in order to understand
the underlying mechanisms. The study should help to provide efficient HEV cell culture systems,
which are urgently needed to enable investigation of HEV replication, neutralization and inactivation.
2. Materials and Methods
2.1. Cells and Viruses
The human liver carcinoma cell lines PLC/PRF/5 (ATCC CRL-8024; LGC Standards GmbH,
Wesel, Germany), HepG2/C3A (ATCC CRL-10741; LGC Standards GmbH), Huh-7 Lunet BLR
(kindly provided by Prof. Dr. Ralf Bartenschlager, University of Heidelberg, Germany), the fetal
lung cell line MRC-5 (ATCC CCL-171; LGC Standards GmbH) as well as the human lung carcinoma
cell line A549 (ATCC CCL-185; LGC Standards GmbH) were used. The HEV genotype 3 strain 47832c
was originally isolated from a chronically infected transplant patient by inoculation onto A549 cells [8].
This strain has been shown to carry an insertion within the hypervariable genome region of the ORF1,
which is derived from the 3′-region of this ORF. An A549 cell line persistently infected with this HEV
strain has been established, which continuously releases HEV into the cell culture medium [8].
2.2. Generation of Clonal Cell Lines from A549 Cell Culture
A549 cells grown in a T25 flask were detached from the surface using trypsin and subsequently
diluted to a concentration of 10 cells per mL in minimum essential medium (MEM) Eagle supplemented
with 1% non-essential amino acids, 1% glutamine, 0.5% gentamicin and 10% fetal calf serum
(FCS; all cell culture media by PAN Biotech GmbH, Aidenbach, Germany). The cells were seeded into
a 96-well plate (100 µL per well) and incubated at 37 ◦C and 5% CO2 in a humidified incubator.
The wells were regularly checked by light microscopy and only wells showing the growth of
a single cellular clone were chosen for subsequent experiments. The culture supernatant was
replaced weekly by fresh medium as above. After generation of a complete monolayer, the cells were
trypsinized and grown successively in 24-well plates, 6-well plates and T25 flasks (Orange Scientific,
Braine-l’Alleud, Belgium).
2.3. Virus Stock Preparation
The A549 cell line persistently infected with the HEV strain 47832c was grown in T25 flasks in
MEM Eagle medium complemented with 1% non-essential amino acids, 1% glutamine, 1% gentamicin
and 2% FCS at 37 ◦C and 5% CO2 in a humidified incubator. After seven days of incubation,
the supernatant was removed, centrifuged to remove cells and stored at −80 ◦C. The cells were
split 1:2 and grown for another seven days until collection of supernatant as above. The stored
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supernatants were tested by HEV-specific quantitative reverse transcription polymerase chain reaction
(RT-qPCR) as described below and those containing high amounts of HEV RNA were pooled.
2.4. HEV Inoculation of Cell Cultures
HEV inoculation trials have been performed in two different laboratories under slightly different
conditions. The initial tests with several different established cell lines were performed in laboratory 1
(Institute of Clinical Microbiology and Hygiene, Regensburg, Germany) and cells were grown in T12.5
flasks in MEM Eagle medium complemented with 1% non-essential amino acids, 1% glutamine,
1% gentamicin, 10 mM MgCl2 and 10% FCS at 37 ◦C and 5% CO2 in a humidified incubator.
The cultures were grown for two weeks (with complete medium replacement every three or four days)
prior to infection. All inoculation experiments were performed in triplicates. Cells were inoculated
with supernatant containing the HEV strain 47832c (8.0 × 106 genome copies/mL; 250 µL/flask for
infection) and incubated at room temperature for 1 h. The virus suspension was replaced by fresh
medium as above and cells were incubated at 34.5 ◦C and 5% CO2. Medium was replaced on day 1, 4,
7, 11 and 14 post inoculation (p.i.) as described above and aliquots were stored for analysis at −80 ◦C.
All other tests were performed in laboratory 2 (Federal Institute for Risk Assessment, Berlin,
Germany) under conditions as described below. For comparison of subclonal cell lines, 24-well plates
(RT-qPCR analysis) or 96-well plates (immunofluorescence analysis) were used. In these cases,
cells were grown for seven days in MEM Eagle medium complemented with 1% non-essential
amino acids, 1% glutamine, 0.5% gentamicin and 10% FCS at 37 ◦C and 5% CO2 in a humidified
incubator. Thereafter, the culture supernatant was exchanged with fresh medium and the cells were
incubated for additional three days as above. The confluent cell monolayers were washed twice with
Dulbecco’s phosphate-buffered saline (DPBS; PAN Biotech GmbH, Aidenbach, Germany) and HEV
(2.4 × 106 genome copies/mL; 200 µL/well for 24-well plates; 90 µL/well of a ten-fold dilution series
for 96-well plates) was added. After incubation for 1 h at room temperature, the virus solution
was removed and the cells were washed three times with PBS. Cell culture medium containing
5% FCS was added. Cells were incubated for seven days at 34.5 ◦C and 5% CO2 and the supernatant
was exchanged by fresh medium containing 5% FCS followed by an additional incubation for
seven days under the same conditions. The time-course analyses of HEV replication in A549,
A549/D3 and A549/DB3 cells were performed in 6-well plates using similar conditions as above
(infection with 5.6 × 106 genome copies/mL; 500 µL /well for infection), but removing half of the
medium every day and replacing it by the same amount of fresh medium. The cells were investigated
by immunofluorescence test (IFT); cell culture supernatants were stored at −20 ◦C and analyzed
by RT-qPCR.
2.5. RT-qPCR
In laboratory 1, which performed the initial tests of different established cell lines, RNA was
isolated from the culture supernatants on an EZ1® Advanced XL workstation using the EZ1 Virus
Mini Kit v2.0 (Qiagen, Hilden, Germany) and tested by RT-qPCR according to Wenzel et al. [14].
HEV RNA concentrations determined by this method are shown as genome copies per mL and the
detection limit of the assay was 25 genome copies. One genome copy is equivalent to 0.586 World
Health Organization (WHO) units (as defined by the 1st WHO International Standard for HEV NAT
Assays, PEI code 6329/10). In laboratory 2, which performed all other experiments, RNA was isolated
using the Nuclisense EasyMag (bioMérieux, Marcy l’Etoile, France) and a real-time RT-qPCR [15]
(detection limit: 68 genome copies) was performed and quantified as described by Schielke et al. [7].
2.6. Immunofluorescence Test
The IFT was performed as described recently [16]. Briefly, the cells were fixed in acetone/methanol,
dried, washed with PBS and blocked with PBS supplemented with 1% FCS. A HEV capsid
protein-specific rabbit hyperimmune serum [16] and fluorescein isothiocyanate (FITC)-conjugated
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anti-rabbit immunoglobulin G (IgG; Sigma, Deisenhofen, Germany) were used for HEV detection.
Cells were analyzed using a Zeiss Axio Observer Z1 microscope (Zeiss, Jena, Germany).
2.7. Transcriptome Analysis
Cells were grown in T25 flasks at conditions as described above. At the time-point of inoculation,
three flasks of each cell line (A549, A549/D3) were removed without infection for transcriptome
analysis. Additional three flasks were inoculated with HEV, which served as controls and were later
tested for virus replication by RT-qPCR. The non-infected cells were washed three times with PBS and
the cellular RNA was isolated using the RNeasy Mini Kit (Qiagen). The RNA of the three replicates
was mixed and subjected to transcriptome analysis using the Affymetrix Human Gene 2.0 ST Array
(Affymetrix, Santa Clara, CA, USA). The transcriptome and data analysis was performed by ATLAS
Biolabs GmbH (Berlin, Germany).
2.8. Antibody Blocking Assay
Cells were seeded into 24-well plates and grown for seven days as described above. The medium
was exchanged and cells were incubated at 37 ◦C for additional three days. After two washing
steps with PBS, 200 µL/well MEM Eagle medium supplemented with 10 µg of the respective
specific rabbit hyperimmune serum was added. CEACAM1-specific (Catalog No. ABIN 1997567),
CEACAM5-specific (Catalog No. ABIN 1998195) and CEACAM6-specific (Catalog No. ABIN 1997583)
sera were purchased from antibodies-online GmbH (Aachen, Germany). Syndecan 2 (SDC2)-specific
antibodies (Catalog No. R30996) originated from NSJ Bioreagents (San Diego, CA, USA). All specific
antisera were previously tested negative for HEV-specific antibodies using an enzyme-linked
immunosorbent assay (ELISA; AXIOM, Bürstadt, Germany). Control wells received no antiserum.
After incubation for 1 h at 37 ◦C, the solution was removed and replaced by 200 µL HEV-containing
culture supernatant (2.4 × 106 genome copies/mL) and incubated at room temperature for 1 h.
The virus solution was removed, the cells were washed three times with PBS and culture medium
containing 10 µg of the respective antiserum and 5% FCS was added. After incubation for seven days
at 34.5 ◦C, the culture supernatant was removed and replaced by fresh medium containing 10 µg of
the respective antiserum and 5% FCS. After additional incubation for seven days at 34.5 ◦C, RNA was
extracted from the culture supernatants and tested by RT-qPCR.
3. Results
3.1. Inoculation of Different Cell Lines with HEV Strain 47832c
The human liver carcinoma cell lines PLC/PRF/5, HepG2/C3A and Huh-7 Lunet BLR, as well
as the lung fibroblast cell line MRC-5 and the human lung carcinoma cell line A549 were inoculated
with the HEV strain 47832c. Culture supernatants were analyzed at 7 and 14 days p.i. by RT-qPCR.
As shown in Figure 1, the highest amounts of the HEV genome were detected in A549 cells and—with
an approximately 5-fold lower amount—in PLC/PRF/5 cells. In contrast, HepG2/C3A, Huh-7 Lunet
BLR and MRC-5 showed only marginal signs of HEV replication, and decreasing HEV genome amounts
between days 7 and 14 p.i. in HepG2/C3A and MRC-5 cells. Based on these results, A549 cells were
selected for further experiments to optimize the HEV cell culture system.
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3.2. Generation and HEV Inoculation of A549-Derived Subclonal Cell Lines 
Subclonal cell lines were generated by seeding and subsequent growing of single cells of the cell 
line A549. From two independent experiments, 16 subclonal cell lines were selected and inoculated 
with the HEV strain 47832c. Analysis of the culture supernatants at 14 days p.i. showed similar or 
lower amounts of the HEV genome as compared to the parental cell line A549 for 15 of the clonal cell 
lines, but an approximately 8-fold higher amount for the subclonal cell line A549/D3 (Figure 2). 
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This result was confirmed by a separate testing of virus growth in A549/D3 cells and A549 cells 
using the slightly modified protocol used in laboratory 1 (data not shown). 
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Figure 1. Replication of hepatitis E virus (HEV) strain 47832c in different cell lines. The mean HEV
genome copy number present in the culture supernatant at 7 and 14 days (d) after inoculation and
the standard deviation (error bars) of three replicates each are shown. For MRC-5 cells at day 14 after
inoculation, HEV-RNA was only detectable in two of the three replicates.
3.2. eneration and E Inoculation of 549- erived Subclonal ell Lines
Subclonal cell lines ere generated by seeding and subsequent gro ing of single cells of the cell
line 549. Fro t o independent experi ents, 16 subclonal cell lines ere selected and inoculated
ith the E strain 47832c. nalysis of the culture supernatants at 14 days p.i. sho ed si ilar or
lo er a ounts of the E geno e as co pared to the parental cell line 549 for 15 of the clonal cell
lines, but an approxi ately 8-fold higher a ount for the subclonal cell line 549/ 3 (Figure 2).
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Figure 2. Replication of HEV strain 47832c in clonal cell lines derived from single A549 cells. The HEV
genome copy number pre ent in the culture supernatant at 14 days a ter infection and th standard
deviation (error bars) of three replicates each are shown.
Viruses 2016, 8, 267 6 of 11
This result was confirmed by a separate testing of virus growth in A549/D3 cells and A549 cells
using the slightly modified protocol used in laboratory 1 (data not shown).
A time course analysis with daily measurement of the HEV genome copy number in the culture
supernatants was performed for the cell line A549 and for the subclonal cell lines A549/D3 and
A549/DB3. As evident from Figure 3, the amount of HEV RNA increased in A549 cells and A549/D3
cells during the first week after infection and remained thereafter at a plateau. Beginning with day 5
p.i., the A549/D3 cells produced higher HEV RNA amounts as compared to the original A549 cells.
In contrast, the HEV RNA amounts in the supernatant of cell line A549/DB3 continuously declined
during this experiment. HEV RNA observed in all cases between day 0 and 2 days p.i. may represent
passive detachment of virus particles bound to the cells.
Light microscopy of the cell line A549 and the subclonal cell lines A549/D3 and A549/DB3
showed that they have similar morphologies; however, A549/D3 cells tended to be larger and showed
a more structured appearance (Figure 4, left panel). No cytopathic effects were evident after HEV
infection for each of the cell lines. Replication of HEV in these cell lines was also analyzed by IFT
using an HEV capsid protein-specific antiserum. To this end, the cell lines were infected with ten-fold
dilutions of HEV strain 47832c and analyzed at 14 days p.i. Productive HEV infection was evident
in case of cell lines A549 and A549/D3 by the presence of fluorescent foci consisting of more than
two adjacent cells showing clear cytoplasmatic fluorescence (Figure 4). These foci were consistently
present after infection with virus dilutions of up to 1:100 in the cell line A549 and for 1:1000 dilutions
in cell line A549/D3. In contrast, only single isolated cells showed fluorescence after infection of
A549/DB3 cells with the undiluted virus suspension.
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Figure 3. Time-course analysis of HEV strain 47832c replication in A549 cells and in the clonal cell
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each are shown.
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Probe ID Gene Symbol Gene Name Fold Change
Upregulated
17071144 SDC2 Syndecan 2 11.005
17107867 MAGEA6/3 Melanoma antigen family A 6 and 3 8.843
17077525 CA8 Carbonic anhydrase VIII 7.308
17023338 RNA5SP216 RNA, 5S ribosomal pseudogene 216 7.219
16948063 NLGN1 Neuroligin 1 6.374
Downregulated
16862563 CEACAM6 Carcinoembryonic antigen-related cell adhesion molecule 6 −50.609
16872621 miscellaneous Chromosome (Chr) 19: 42219580–42223939 −23.484
16862548 CEACAM5 Carcinoembryonic antigen-related cell adhesion molecule 5 −21.642
16738803 TCN1 Transcobalamin I −18.276
16879863 EPCAM Epithelial cell adhesion molecule −13.057
A similar transcriptome analysis was performed with the subclonal cell line A549/DB3 compared
to A549 cells. The genes showing the highest up- and downregulation in A549/DB3 cells are different
from that identified in A549/D3 cells (Table S1).
3.4. Effect of Anti-CEACAM and Anti-SDC2 Antibodies on HEV Replication in A549/D3 and A549 Cells
As the products of the CEACAM and syndecan gene families are membrane-bound surface proteins,
a blocking of them with antibodies, which possibly prevent the interaction with HEV, was analyzed.
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To this end, A549 cells and A549/D3 cells were incubated with CEACAM1-, 5- and 6- as well as
SDC2-specific antibodies before inoculation with HEV strain 47832c. These antibodies were also
supplemented in the culture medium after inoculation. Cells infected and incubated in the absence of
specific antibodies served as negative controls. As evident from Figure 5, no significant differences
could be found in both cell lines between HEV genome copy numbers in the culture supernatant at
14 days p.i. in the presence or absence of the specific antibodies.
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Figure 5. Effect of treatment of cells with carcinoembryonic antigen-related cell adhesion molecule
(CEACAM)- and syndecan 2 (SDC2)-specific antibodies on the replication of HEV strain 47832c.
A459 cells and A549/D3 cells were incubated with or without CEACAM1-, 5-, 6- and SDC2-specific
antisera prior a d after HEV inoculation. The HEV genome copy number present in the culture
supernata t at 14 d ys after infection and the standa d deviation (error bars) of hre replicates each
are shown.
4. Discussion
Although the isolation of several HEV strains in different cell culture systems has been described
repeatedly, their replication is mostly slow, inefficient and r quires larg amount of inoculum.
Howev r, efficient cell culture systems for HEV are urgently ne ded to investig te its repli ation
cycle as w ll as neutr lizati n and inactivation properties. Therefore, the growth of n already cell
culture-isolated HEV strain should be optimized in this study. The strain 47832c, originally isolated
from a chronically infected transplant patient, was sele ted as it belongs to the currently emerging
genotype 3 of HEV and showed robust cell cultur replication in previous studies [8]. The strain
c ntains a specific genome i sertion within the h pervariable region of its ORF1, which may be
involved in stable r plication in cell culture. As only this strain has been tested in this study, it remains
uncl ar whether other strains show the same replication properties in the cell lines analyzed here.
In a first attempt f optimization, s veral human cell lines have been t sted. The liver cell lines
PLC/PRF/5, HepG2/C3A and Hu -7 have been lready described to support HEV replication [4,6,17].
In our experiments, how ver, only PLC/PRF/5 led to efficient virus replication. Althoug the liver
cell is susp cted to be the main target of HEV, the specific requirements for HEV replicatio in
c ltured liver cells are not yet known. The fetal lung cell line MRC-5 only marginally supported HEV
replication, whereas the cell line A549 derived from lung carcinoma cells showed the best replication
efficiency. A549 cells have been repeatedly described in s ccessf l is lati e eri ents [18–20];
also, strain 47832c has been originally isolated in this cell line. The distinct properties of this cell line
leading to HEV susceptibility should be investigated in more detail.
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Based on a hypothesis that the A549 cell line is a mixture of different cell types, subclonal
cell lines were generated. The fact that the subclonal cell lines showed marked differences in HEV
replication efficiency confirms this hypothesis and underlines the heterogeneity of A549 cells. In this
context, it should also be considered that the A549 cell lines used in different laboratories may be
heterogeneous and therefore show different efficiencies of HEV replication. Subclonal cell lines with
differing efficiency of HEV replication have also been described very recently for the PLC/PRF/5 cell
line [21], thus indicating that this phenomenon is not unique for A549 cells. The selected subclonal
cell lines may later be used in improved HEV cell culture systems. The resulting subclonal cell line
A549/D3 has already been applied in a titration system for testing the heat stability of HEV [16].
In order to investigate the underlying mechanism of enhanced HEV replication, a transcriptome
analysis was performed for the subclonal cell line A549/D3. Among others, this led to the identification
of CEACAM genes, which encode membrane-bound members of the immunoglobulin superfamily,
overexpressed in many cancers and associated with adhesion and invasion [22,23]. In addition,
CEACAM6 was reported to attenuate the adenovirus infection in cancer cells by antagonizing
intracellular trafficking [24]. In order to investigate if these molecules bind HEV and thereby prevent
its replication in A549 cells compared to A549/D3 cells, an antibody blocking experiment was
performed. Another identified gene of a membrane-bound protein was the SDC2 gene, which was
upregulated in A549/D3 cells. Syndecans are heparan sulfate proteoglycans [25], which already have
been shown to be capable of HEV capsid protein binding [26] and have been found as a potential
Dengue virus receptor in vitro [27]. Therefore, blocking experiments should indicate if these molecules
are responsible for enhanced uptake of HEV into A549/D3 cells followed by increased replication.
However, no effect either of the CEACAM-specific antibodies or of the SDC2-specific antibodies could
be found in the experiments presented here. Therefore, either these molecules are acting by more
indirect mechanisms or their up- or downregulation is not the cause of the improved HEV replication
in A549/D3 cells. In a similar analysis of A549/DB3 cells, other genes were up- or downregulated,
indicating that a different mechanism leads to the very low HEV replication activity of these cells.
Very recently, the asialoglycoprotein receptor has been identified as a molecule facilitating HEV
infection in PLC/PRF/5 cells [28]. However, no differences could be found in the expression levels
of this gene between A549 and A549/D3 or A549/DB3 cells, thus excluding this molecule as the
cause of different replication efficiency in these cell lines. Further experiments should also include
transcriptome analyses of HEV-infected cells as HEV may modulate cellular gene expression during
its replication as recently shown for antiviral innate immunity pathways [29,30].
In conclusion, the cell culture system for HEV was improved by the generation of the clonal
cell line A549/D3, which now can be used for the investigation of the HEV replication cycle and its
neutralization and inactivation properties. Further improvements of the system may be achieved by
testing different cell culture conditions and supplements. In addition, further investigations should be
initiated to unravel the mechanism of improved replication in these cells. The identification of specific
cellular factors supporting HEV replication would allow a more targeted improvement of HEV cell
culture systems and provide general insights into the virus-host cell interplay during HEV infection.
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